Literature DB >> 35037128

Morphological alteration of the pancreatic islet in ovariectomized rats fed a high-fat high-fructose diet.

Piyachat Chansela1, Bubphachat Potip2, Jittima Weerachayaphorn2, Niwat Kangwanrangsan3, Natsasi Chukijrungroat2, Vitoon Saengsirisuwan4.   

Abstract

Diabetes and its complications are major causes of mortality worldwide. Type 2 diabetes coexists with insulin resistance and β-cell dysfunction, which are aggravated by overconsumption and estrogen-deprived conditions. However, the morphology of pancreatic islets in a combined condition of excessive caloric intake and estrogen deficiency has never been described. Herein, we examined morphological changes in the pancreatic islets of ovariectomized (OVX) rats fed a high-fat high-fructose diet (HFFD) for 12 weeks. The histological changes in the size and number of pancreatic islets were assessed by hematoxylin-eosin and immunohistochemical staining. Enlarged pancreatic islets with fat deposition in OVX rats were accompanied by whole-body insulin resistance and hyperglycemia. The addition of a HFFD to OVX rats (OVX + HFFD) further aggravated insulin resistance, with a substantial increase in the density of enlarged pancreatic islets and fat accumulation. The augmented number of enlarged islets was correlated with elevated plasma glucose and insulin levels. Intriguingly, unlike the HFFD and OVX alone, the OVX + HFFD markedly expanded the area of insulin-producing β-cells and glucagon-producing α-cells. Importantly, enlarged islets, pancreatic fat deposits, and diabetic states developing in OVX + HFFD conditions were resolved by estrogen replacement. Collectively, the morphological characteristics of pancreatic islets were influenced in an insulin-resistant state caused by estrogen deficiency and HFFD consumption and were distinct from each factor alone. A combination of estrogen deficiency with HFFD consumption worsened the integrity of pancreatic islets, ultimately resulting in disease progression. These findings expand our understanding of the causal relationship between pancreatic morphology and diabetes development and suggest therapeutic strategies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Estrogen; High-fat high-fructose diet; Insulin resistance; Pancreatic β-cells

Mesh:

Substances:

Year:  2022        PMID: 35037128     DOI: 10.1007/s00418-021-02062-0

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  38 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Effects of 17β-estradiol and antioxidant administration on oxidative stress and insulin resistance in ovariectomized rats.

Authors:  Amr M Abbas; Ayman Z Elsamanoudy
Journal:  Can J Physiol Pharmacol       Date:  2011-07       Impact factor: 2.273

3.  High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.

Authors:  Michal Ganz; Timea Csak; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Characterization of the glucagon response to hypoglycemia in man.

Authors:  J E Gerich; V Schneider; S E Dippe; M Langlois; C Noacco; J H Karam; P H Forsham
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

5.  Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver.

Authors:  Natsasi Chukijrungroat; Tanaporn Khamphaya; Jittima Weerachayaphorn; Thaweesak Songserm; Vitoon Saengsirisuwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-30       Impact factor: 4.310

6.  Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes.

Authors:  Elizabeth Barrett-Connor; Kristine E Ensrud; Kristine Harper; Timothy M Mason; Andreas Sashegyi; Kathryn A Krueger; Pamela W Anderson
Journal:  Clin Ther       Date:  2003-03       Impact factor: 3.393

Review 7.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

9.  Reversible changes in pancreatic islet structure and function produced by elevated blood glucose.

Authors:  Melissa F Brereton; Michaela Iberl; Kenju Shimomura; Quan Zhang; Alice E Adriaenssens; Peter Proks; Ioannis I Spiliotis; William Dace; Katia K Mattis; Reshma Ramracheya; Fiona M Gribble; Frank Reimann; Anne Clark; Patrik Rorsman; Frances M Ashcroft
Journal:  Nat Commun       Date:  2014-08-22       Impact factor: 14.919

Review 10.  The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.

Authors:  Philipp A Gerber; Guy A Rutter
Journal:  Antioxid Redox Signal       Date:  2016-06-30       Impact factor: 8.401

View more
  1 in total

1.  Long-Term High-Fat High-Fructose Diet Induces Type 2 Diabetes in Rats through Oxidative Stress.

Authors:  Yue Zhao; Qing-Yu Wang; Lv-Tao Zeng; Jing-Jing Wang; Zhen Liu; Guo-Qing Fan; Jin Li; Jian-Ping Cai
Journal:  Nutrients       Date:  2022-05-24       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.